What You Should Know About Ovarian Cancer Vaccines
Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...
Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Third cohort dose is one million CAR positive cells; ten times higher than the first cohort dose . SAN JOSE, Calif., Nov. 18, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" ...
mayo2d
Project 1: Next-Generation TOP1 Inhibition To Treat Ovarian Cancer
TOP1 is the target of topotecan, which was approved in 1997 by the U.S. Food and Drug Administration (FDA) to treat relapsed ...
thehealthy2d
Patrick Dempsey Opens Up About His Passion for Cancer Awareness
It’s hard to believe it was almost 20 years ago when in 2005, Patrick Dempsey originated the role of Dr. Derek Shepherd in a ...
Medpage Today on MSN4d
Adding HIPEC Boosts Survival in Recurrent Ovarian Cancer
The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...
mayo2d
Project 4: Th17 T Cell-Inducing Vaccines for the Prevention of Ovarian Cancer Recurrence
It induces a specific type of immunity, called Th17 immunity, that seems to prevent suppression of the immune system. The ...
Radio Iowa5d
UI is crafting a new drug to treat ovarian cancer
University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill ...
Kathy Bates Reveals Why She Decided Against Reconstruction After Breast Cancer: 'I Enjoy Not Having Breasts'
Kathy Bates has revealed why she decided against reconstruction surgery after her breast cancer diagnosis and mastectomy in ...
The American Journal of Managed Care5d
Ovarian Cancer Survival Varies Widely Among Asian American Subgroups
Researchers found significant differences in ovarian cancer survival among Asian American subgroups, emphasizing the ...